Golkunda Diamond (523676)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• High capital efficiency with ROE of 21.10% and ROCE of 19.88%
• Still profitable in the latest quarter: ₹4 Cr net profit on ₹63 Cr sales
• P/E of 16.66 is not excessive if earnings stabilise
• Book value of ₹84.88 provides some tangible asset backing

Concerns

• Sales down 15.18% and profit down 28.19% year-on-year
• Piotroski F-score of 3/9 signals weak underlying fundamentals
• P/B of 2.51 is expensive for a shrinking earnings base
• Promoter holding not disclosed, poor governance visibility; dividend yield just 0.52%

AI Analysis

At first glance Golkunda Diamond earns impressive returns: ROE of 21.10% and ROCE of 19.88% suggest a well-managed enterprise. But I have to separate a good business from a good investment. This is a cyclical, fragmented segment — gems and jewellery — where demand, rough diamond prices and working capital cycles dictate results. Last year confirms that: sales fell 15.18% and profits fell 28.19%. The latest quarter still shows a profit of ₹4 Cr on sales of ₹63 Cr, so the company is not in distress, but momentum is clearly negative. The Piotroski F-score of 3/9 worries me deeply; it points to deteriorating financial fundamentals, despite the glossy ROE. I also see no genuine moat here. Diamond processing is competitive, and Golkunda likely has limited pricing power. Promoter holding is not disclosed, which is a red flag for a retail investor; I like to know who owns the business and whether their interests align with mine. On valuation, the stock trades at ₹213.10 versus a book value of ₹84.88, meaning you pay 2.51 times book. That is not cheap for a business whose sales and earnings are shrinking. The P/E of 16.66 is moderate, but it could become optically expensive if profits fall further. The dividend yield of 0.52% offers little comfort. The 52-week range of ₹156 to ₹314.90 shows real volatility, and the current price is lower than the high, but a falling share price is not the same as intrinsic value. I would need evidence of stabilising demand, improved F-score, and a clear reversal in quarterly earnings before treating this as a serious value candidate. Until then, this is a cyclical battleground, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer